000119670 001__ 119670
000119670 005__ 20240228134948.0
000119670 0247_ $$2doi$$a10.1158/0008-5472.CAN-14-1424
000119670 0247_ $$2pmid$$apmid:25136075
000119670 0247_ $$2ISSN$$a0008-5472
000119670 0247_ $$2ISSN$$a0099-7013
000119670 0247_ $$2ISSN$$a0099-7374
000119670 0247_ $$2ISSN$$a1538-7445
000119670 0247_ $$2altmetric$$aaltmetric:2646239
000119670 037__ $$aDKFZ-2017-00301
000119670 041__ $$aeng
000119670 082__ $$a610
000119670 1001_ $$0P:(DE-He78)a371343639d3cdfb2fd17b0330c9f593$$aBöck, Barbara$$b0$$udkfz
000119670 245__ $$aMouse models of human cancer.
000119670 260__ $$aPhiladelphia, Pa.$$bAACR$$c2014
000119670 3367_ $$2DRIVER$$aarticle
000119670 3367_ $$2DataCite$$aOutput Types/Journal article
000119670 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1488542258_12068
000119670 3367_ $$2BibTeX$$aARTICLE
000119670 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000119670 3367_ $$00$$2EndNote$$aJournal Article
000119670 520__ $$aThe Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC; www.helmholtz-pccc.de) hosted the '1st International Kloster Seeon Meeting on Mouse Models of Human Cancer' in the Seeon monastery (Germany) from March 8 to 11, 2014. The meeting focused on the development and application of novel mouse models in tumor research and high-throughput technologies to overcome one of the most critical bottlenecks in translational bench-to-bedside tumor biology research. Moreover, the participants discussed basic molecular mechanisms underlying tumor initiation, progression, metastasis, and therapy resistance, which are the prerequisite for the development of novel treatment strategies and clinical applications in cancer therapy.
000119670 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000119670 588__ $$aDataset connected to CrossRef, PubMed,
000119670 7001_ $$0P:(DE-HGF)0$$aStein, Ulrike$$b1
000119670 7001_ $$0P:(DE-HGF)0$$aSchmitt, Clemens A$$b2
000119670 7001_ $$0P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b$$aAugustin, Hellmut$$b3$$eLast author$$udkfz
000119670 773__ $$0PERI:(DE-600)2036785-5$$a10.1158/0008-5472.CAN-14-1424$$gVol. 74, no. 17, p. 4671 - 4675$$n17$$p4671 - 4675$$tCancer research$$v74$$x1538-7445$$y2014
000119670 909CO $$ooai:inrepo02.dkfz.de:119670$$pVDB
000119670 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a371343639d3cdfb2fd17b0330c9f593$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000119670 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000119670 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000119670 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000119670 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000119670 9141_ $$y2014
000119670 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000119670 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER RES : 2015
000119670 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000119670 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000119670 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000119670 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000119670 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000119670 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000119670 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000119670 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000119670 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000119670 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000119670 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000119670 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER RES : 2015
000119670 9201_ $$0I:(DE-He78)A190-20160331$$kA190$$lVaskuläre Onkologie und Metastasierung$$x0
000119670 9201_ $$0I:(DE-He78)L201-20160331$$kL201$$lDKTK Berlin$$x1
000119670 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000119670 980__ $$ajournal
000119670 980__ $$aVDB
000119670 980__ $$aI:(DE-He78)A190-20160331
000119670 980__ $$aI:(DE-He78)L201-20160331
000119670 980__ $$aI:(DE-He78)L101-20160331
000119670 980__ $$aUNRESTRICTED